External Ventricular Drain Market Synopsis:
\nExternal Ventricular Drain Market Size Was Valued at USD 6.96 Billion in 2023, and is Projected to Reach USD 12.32 Billion by 2032, Growing at a CAGR of 6.54% From 2024-2032.
\nThe external ventricular drain (EVD) market deals with devices employed to remove cerebrospinal fluid (CSF) from the ventricles of the brain. EVDs are used mainly in the treatment of diseases including hydrocephalus, traumatic brain injury as well as subarachnoid haemorrhage. These modern instruments include a catheter which is implanted directly into the brain\u2019s ventricular system through which a controlled procedure is performed to siphon the extra fluid here, thereby releasing pressure and avoiding harm to neurons. The market includes a wide range of EVDs, attaching accessories and other related devices and new solutions for EVDs are being developed to increase safety and efficacy for patients.
\nThe external ventricular drain market has been growing since the prevalence of neurological disorders and trauma cases with patients seeking better treatment. Hydrocephalus, for instance, is not a well understood condition around the globe, but as the condition gains awareness, people require effective drain services. Moreover, the development in technology also supports improvement in the design of EVDs including pressure monitoring and infection control features. The growth of this market is influenced by such factors as the increase in life expectancy of the population, the elderly, many of whom are at high risk of developing neurological disorders.
\nThe number of surgeries in the market that include EVDs is on a rise due to better infrastructure and increased availability of neurological treatments. The availability of new LUMEN enabling minimally invasive surgery and advancement in the catheter materials are also having an impact. More so, improved marketing has emerged as a driving force, with firms directing efforts to research and development of the products. The market is quite competitive since there are well-developed companies and relatively newer players that are coming into the market and thus providing greater plurality for development.<\/p>\n
External Ventricular Drain Market Trend Analysis:
\nRising Demand for Minimally Invasive Procedures<\/p>\n
Identifiable trend in the external ventricular drain market is the shift towards minimally invasive surgical operations. This change process is primarily due to the less invasive procedure being facilitated by a combination of technology. This has the advantages such as short or no hospitalization, few chances of sepsis, and smallest amount of pain after the surgery. For this reason, these approaches are being applied by healthcare providers for the intended effectiveness and therefore a growing need for sophisticated EVD systems that would enable such procedures. The increasing utilization of in imaging machinery and real time monitoring equipment with EVDs is promoting the boost of this trend.<\/p>\n
Moreover, Plus, growth of activity and concern among patients contributes to the trend\u2019s development civil due to the fact that more and more patients realize the advantages of minimally invasive procedures. Due to increased awareness by patients through the advance in technology on their conditions and treatment, patients are demanding for procedures that offer them fast recovery and little or no side effects. This necessity is making manufacturers to come up with better and improved design that solves the need of the surgeons as well as patients. Therefore, the EVD market is witnessing trends in relation to product development to meet the changes ailing the healthcare systems for both the professionals and the patients.
\nExpansion in Emerging Markets<\/p>\n
In assessing future prospective for the EVD market, one of the strongest potential drivers of the market\u2019s growth is the need to capture the growth in emerging markets. Places like Asia-Pacific and Latin America are extending the healthcare spending, making people to access more advanced health technologies. With the sophistication of these market, there is thus the need to ensure that neurological disorders such as the use of EVDs are effectively handled. Those organizations that are strategically placed to capture these markets will equally be able to benefit from the expanding demand which is further underpinned by government efforts to enhance health care sectors.
\nExternal Ventricular Drain Market Segment Analysis:
\nExternal Ventricular Drain Market is Segmented on the basis of type, application, end user, and region
\nBy Type, Pediatric segment is expected to dominate the market during the forecast period<\/p>\n
The pediatric segment is projected to hold the largest share of the external ventricular drain market in the course of the forecast period for various neurological disorders that are increasingly affecting children, such as hydrocephalus and traumatic brain injuries. Children commonly deserve precision in the management of their health complications and need individualised EVD treatment plans due to the differences in organ anatomic and physiological status between an infant and an adult patient. Furthermore, trends indicate the creation of new models of EVD systems that are compact, and suitable for pediatric patients which increases the safety of the procedure. As care delivery organizations strive to amplify procedural success rates for youngsters, there are increased chances of growth for pediatric categories based on clinical requirements and advancements in medical technology.
\nBy Application, Traumatic Brain Injury segment expected to held the largest share <\/p>\n
The segment that is related to traumatic brain injury (TBI) is anticipated to dominate the external ventricular drain market thanks to the growing TBI rates across the world resulting from factors such as, road traffic mishaps, sports, and falls. The complications that are associated with TBI include elevated intracranial pressure, and treatment is usually in form of external ventricular drain. People becoming aware of the long-term consequences of TBI consequent to interventions, and healthcare organizations are now focusing on early intervention management techniques with or without EVDs. Also, the improvements in the surgical procedures and the device technology are also improving the safety and efficacy of the EVDs in TBI procedures, thereby strengthening the major segment share in the market significantly.
\nExternal Ventricular Drain Market Regional Insights:
\nNorth America is Expected to Dominate the Market Over the Forecast period <\/p>\n
The external ventricular drain market by region of origin shows that in 2023 North America dominated the global market share of about 40%. This important market share could be mainly attributed to the aspect that it has well developed health care systems, high incidences of neurological ailments, and substantial focus on innovation. This programme has long-standing links with the United States, a country with advanced medical equipment manufacturing industry where there are many key manufacturers of EVD technologies. Also, skilled human resource in healthcare, and well-equipped neurosurgical centers also contribute to the utilization of EVDs in this region.
\nActive Key Players in the External Ventricular Drain Market:<\/p>\n
Aesculap (Germany)<\/p>\n
Asahi Intecc (Japan)<\/p>\n
B. Braun Melsungen AG (Germany)<\/p>\n
Becton Dickinson and Company (USA)<\/p>\n
Codman Neuro (USA)<\/p>\n
Integra LifeSciences (USA)<\/p>\n
Johnson & Johnson (USA)<\/p>\n
Medtronic (USA)<\/p>\n
Merit Medical Systems (USA)<\/p>\n
Natus Medical Incorporated (USA)<\/p>\n
Neurovascular (USA)<\/p>\n
R. P. Scherer GmbH (Germany)<\/p>\n
Smiths Medical (USA)<\/p>\n
SOPHYSA (France)<\/p>\n
Spiegelberg GmbH (Germany)<\/p>\n
Other Active Players<\/p>\n","protected":false},"excerpt":{"rendered":"
The external ventricular drain (EVD) market deals with devices employed to remove cerebrospinal fluid (CSF) from the ventricles of the brain.<\/p>\n","protected":false},"featured_media":24152,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-26961","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n